Log in or Sign up for Free to view tailored content for your specialty!
Oncology News
Survey: 20% of women with high deductible would forgo testing after abnormal mammogram
One in five women with high-deductible health insurance plans who had an abnormal screening mammogram would opt out of follow-up testing, according to survey results presented at the Radiological Society of North America annual meeting.
Cervical cancer screening decreased among older women but may remain higher than needed
Despite decreases in cervical cancer screenings between 1999 and 2019 among older women with Medicare fee-for-service coverage, this group may be overspending on screening-related services, according to data in JAMA Internal Medicine.
Log in or Sign up for Free to view tailored content for your specialty!
Top in hem/onc: Alcohol and cancer risk unawareness; professional wellness
Although data show a clear link between alcohol consumption and an increased risk for certain cancers, a high percentage of adults in the United States were unaware of the association, according to recent study results.
Healio Minute Podcast, Hematology Oncology Edition: Top Headlines - Week of December 5, 2022
In this edition, fludarabine has been placed on the FDA’s drug shortage list; epcoritamab is approved for advanced lymphoma; pembrolizumab with chemotherapy improves OS in gastric cancer, and more.
Cancer risk similar in patients treated with TNF inhibitors, other targeted therapies
PHILADELPHIA — Patients with rheumatic diseases and previous malignancy do not demonstrate a higher cancer risk with TNF inhibitors vs. other biologic and targeted synthetic DMARDs, according to data presented at ACR Convergence 2022.
Top in hem/onc: Molecular testing in lung cancer; gender disparities in NIH funding
Despite its benefits, data suggest that comprehensive molecular testing in patients with non-small cell lung cancer is underutilized due to a lack of resources.
Healio Minute Podcast, Hematology Oncology Edition: Top Headlines - Week of November 28, 2022
In this edition, disparities among women in the surgical workforce, GSK withdraws belantamab mafodotin from US market, risk for lymphoma low after postmastectomy reconstruction, and more.
Developing Plans for Patient and Trainee Education with Daniel Golden, MD
In this episode, host Shikha Jain, MD, speaks with Daniel Golden, MD, about how he has developed educational tools for patients and students, the importance of embracing your niche in medicine and more.
Healio Minute Podcast, Hematology Oncology Edition: Top Headlines - Week of November 21, 2022
In this edition, lung cancer screening critically low across the U.S, first in-human CRISPR test with gene replacement, racial and economic segregation linked to higher cancer mortality rates, and more.
Q&A: ‘Promising’ immunotherapies may treat platinum-resistant ovarian cancer
During their lifetime, one in 70 women will receive a diagnosis of ovarian cancer, which is the second most common gynecologic cancer in the United States, according to Memorial Sloan Kettering Cancer Center.
-
Headline News
Q&A: Oral injuries could be signs of abuse, neglect
September 04, 20245 min read -
Headline News
Providing menstrual products in schools ‘critical step’ to address period poverty
September 04, 20243 min read -
Headline News
Access to care, education may improve early introduction of allergens into infant diets
September 05, 20247 min read
-
Headline News
Q&A: Oral injuries could be signs of abuse, neglect
September 04, 20245 min read -
Headline News
Providing menstrual products in schools ‘critical step’ to address period poverty
September 04, 20243 min read -
Headline News
Access to care, education may improve early introduction of allergens into infant diets
September 05, 20247 min read